Lucia Alvarez, MD
Cardiovascular Disease · Atlanta, GANPI 1477815207
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by Abbott at 56.6% of the total. Reporting peaked in 2024 at $1,143 and has fallen 75.7% since, to $278 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in GA, where the typical reported total is $2,276.
Across 31 payments — averaging $60.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Boston Scientific$443
- Edwards Lifesciences$251
- Heartflow, Inc.$103
- Lantheus Medical Imaging, Inc.$22
What the payments were for
- Travel & lodging$99753%
- Food & beverage$88947%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 8 | $1,067 |
| Boston Scientific | 19 | $443 |
| Edwards Lifesciences | 2 | $251 |
| Heartflow, Inc. | 1 | $103 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$149
- FFRct$103
How this compares
$1,886 in reported general payments places this provider in the 45th percentile of 640 cardiovascular disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 124 | $142,411 |
| XareltoRivaroxaban | 19 | $29,548 |
| Metoprolol Succinate | 128 | $1,498 |
| Ezetimibe | 67 | $1,433 |
| Atorvastatin Calcium | 126 | $863 |
| Rosuvastatin Calcium | 86 | $824 |
| Losartan Potassium | 100 | $753 |
| Flecainide Acetate | 21 | $663 |
| Lisinopril | 48 | $519 |
| Midodrine Hcl | 14 | $478 |
| Amlodipine Besylate | 94 | $422 |
| Potassium Chloride | 26 | $407 |
| Torsemide | 20 | $311 |
| Hydralazine Hcl | 25 | $270 |
| Spironolactone | 13 | $249 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Atlanta
- Joseph MillerAtlanta$573K
- Utpal PandyaAtlanta$221K
- Randolph MartinAtlanta$177K
- Mani VannanAtlanta$157K
- Victor CorriganAtlanta$114K
- Elizabeth OfiliAtlanta$107K
- Isida BykuAtlanta$78K
- Cindy GrinesAtlanta$75K
- Anekwe OnwuanyiAtlanta$56K
- Melvin EcholsAtlanta$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.